NICE Ltd. NICE
96.68 USD +0.53 (+0.55%)
At closeNov 10, 2026, 4:01 AM EST
96.68 0.00 0.00%
Pre-market · Nov 10, 4:01 AM ET
95.53 Day range 98.11
83.10 52-week range 136.53
- YTD
- -14.47%
- 1 year
- -22.03%
News
seekingalpha.com NICE Ltd. Is Growing While The Market Stays Skeptical NICE Ltd. maintains a Strong Buy rating, supported by resilient revenue growth, robust AI ARR up 46%, and an expanding CXone backlog. Despite margin compression and integration costs, NICE reiterates…
benzinga.com RBC Capital Maintains Outperform on NICE, Lowers Price Target to $130 RBC Capital analyst Rishi Jaluria maintains NICE (NASDAQ:NICE) with a Outperform and lowers the price target from $145 to $130.- benzinga.com Citizens Maintains Market Outperform on NICE, Lowers Price Target to $158 Citizens analyst Patrick Walravens maintains NICE (NASDAQ:NICE) with a Market Outperform and lowers the price target from $170 to $158.
marketbeat.com NiCE Q3 Earnings Call Highlights NiCE NASDAQ: NICE reported third-quarter revenue and adjusted earnings above the high end of its guidance, while management said it is taking steps to improve cloud growth and streamline operations…
seekingalpha.com NICE Ltd. (NICE) Q3 2026 Earnings Call Transcript NICE Ltd. (NICE) Q3 2026 Earnings Call Transcript
zacks.com Nice (NICE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Nice (NICE) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall…
benzinga.com NICE Q3 2026 Earnings Call Transcript NICE (NASDAQ:NICE) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
globenewswire.com Rhythm Pharmaceuticals Announces NICE Guidance for IMCIVREE® (Setmelanotide) Updated to Include Adults Living with Bardet-Biedl Syndrome -- Expanded guidance based on additional evidence demonstrating the benefits of IMCIVREE in adults living with Bardet-Biedl syndrome -- BOSTON, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Rhythm…
benzinga.com 12 Information Technology Stocks Moving In Wednesday's Pre-Market Session Gainers Helport AI (NASDAQ:HPAI) shares moved upwards by 40.0% to $0.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $9.0 million. CPS Technologies…
benzinga.com NICE Q3 Adj. EPS $2.84 Beats $2.77 Estimate, Sales $790.741M Beat $785.925M Estimate NICE (NASDAQ:NICE) reported quarterly earnings of $2.84 per share which beat the analyst consensus estimate of $2.77 by 2.16 percent. This is a 10.69 percent decrease over earnings of $3.18 per share…
businesswire.com NiCE Exceeds Revenue and EPS Guidance Ranges, Reporting 8% Year-Over-Year Revenue Growth in Third Quarter 2026 HOBOKEN, N.J.--(BUSINESS WIRE)--NiCE (NASDAQ: NICE) today announced results for the third quarter ended September 30, 2026, as compared to the corresponding period of the previous year. Third Quarter…